Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Application of Multi-Component Liquid Biopsy (ctDNA, utDNA, Exosomes, and Protein Biomarkers in Blood and Urine) for Auxiliary Diagnosis, Therapeutic Response Evaluation, and Recurrence Monitoring in Urothelial Carcinoma
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Suspected or histologically confirmed urothelial carcinoma
Locations
Other Locations
China
The second hospital of Tianjin Medical University
RECRUITING
Tianjin
Contact Information
Primary
Hailong Hu, MD
huhailong@tmu.edu.cn
+8613662096232
Time Frame
Start Date: 2026-03
Estimated Completion Date: 2029-01-01
Participants
Target number of participants: 300
Treatments
Study group
Related Therapeutic Areas
Sponsors
Leads: Tianjin Medical University Second Hospital